Tubulin isoforms identified in the brain by MALDI in-source decay

Journal of Proteomics

Volumn 79, Issue , 2013, Pages 172-179

  Ait Belkacem, Rima ^a   Calligaris, David ^b   Sellami, Lyna ^a   Villard, Claude ^a   Granjeaud, Samuel ^c   Schembri, Thérèse ^a   Berenguer, Caroline ^a   Ouafik, L'Houcine ^a   Figarella Branger, Dominique ^a   Chinot, Olivier ^a   Lafitte, Daniel ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Biomarker discovery; In source decay; Tubulin; Tubulin isotypes

Indexed keywords

ISOPROTEIN; TUBULIN;

ANIMAL TISSUE; ARTICLE; FRAGMENTATION REACTION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; HELA CELLS; HUMANS; MICE; PROTEIN ISOFORMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUBULIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84872577535     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.11.026     Document Type: Article

References (28)

1. Verdier-Pinard P., Pasquier E., Xiao H., Burd B., Villard C., Lafitte D., et al. Tubulin proteomics: towards breaking the code. Anal Biochem 2009, 384(2):197-206.
2. Lu Q., Luduena R.F. Removal of beta III isotype enhances taxol induced microtubule assembly. Cell Struct Funct 1993, 18(3):173-182.
3. Ranganathan S., Dexter D.W., Benetatos C.A., Chapman A.E., Tew K.D., Hudes G.R. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance. Cancer Res Jun 1 1996, 56(11):2584-2589.
4. Kavallaris M., Kuo D.Y., Burkhart C.A., Regl D.L., Norris M.D., Haber M., et al. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J Clin Invest Sep 1 1997, 100(5):1282-1293.
5. Ranganathan S., Benetatos C.A., Colarusso P.J., Dexter D.W., Hudes G.R. Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells. Br J Cancer Feb 1998, 77(4):562-566.
6. Kavallaris M., Burkhart C.A., Horwitz S.B. Antisense oligonucleotides to class III beta-tubulin sensitizes drug-resistant cells to Taxol. Br J Cancer Jun 1999, 80(7):1020-1025.
7. Banerjee A. Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Biochem Biophys Res Commun Apr 26 2002, 293(1):598-601.
8. Mozzetti S., Ferlini C., Concolino P., Filippetti F., Raspaglio G., Prislei S., et al. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin Cancer Res Jan 1 2005, 11(1):298-305.
9. Gan P.P., McCarroll J.A., Byrne F.L., Garner J., Kavallaris M. Specific β-tubulin isotypes can functionally enhance or diminish epothilone B sensitivity in non-small cell lung cancer cells. PLoS One 2011, 6(6):e21717. [Epub 2011 Jun 29].
10. Bonnel D., Longuespee R., Franck J., Roudbaraki M., Gosset P., Day R., et al. Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer. Anal Bioanal Chem Jul 2011, 401(1):149-165.
11. Debois D., Bertrand V., Quinton L., De Pauw-Gillet M.C., De Pauw E. MALDI-in source decay applied to mass spectrometry imaging: a new tool for protein identification. Anal Chem 2010, 82(10):4036-4045.
12. Demeure K., Gabelica V., De Pauw E.A. New advances in the understanding of the in-source decay fragmentation of peptides in MALDI-TOF-MS. J Am Soc Mass Spectrom 2010, 21(11):1906-1917.
13. Gabelica V., Schulz E., Karas M. Internal energy build-up in matrix-assisted laser desorption/ionization. J Mass Spectrom 2004, 39(6):579-593.
14. Takayama M. Susceptible region of myoglobins to in-source decay using matrix-assisted laser desorption/ionization coupled with reflectron time-of-flight mass spectrometer. J Mass Spectrom Soc Jpn 2002, 50:304-310.
15. Takayama M. N-Ca bond cleavages of the peptide backbone via hydrogen abstraction. J Am Soc Mass Spectrom 2001, 12:1044-1049.
16. Sakakura M., Takayama M. In-source decay and fragmentation characteristics of peptides using 5-aminosalicylic acid as a matrix in matrix-assisted laser desorption/ionization mass spectrometry. J Am Soc Mass Spectrom Jun 2010, 21(6):979-988.
17. Demeure K., Quinton L., Gabelica V., De Pauw E. Rational selection of the optimum MALDI matrix for top-down proteomics by in-source decay. Anal Chem 2007, 79(22):8678-8685.
18. Sachon E., Clodic G., Blasco T., Jacquot Y., Bolbach G. In-source fragmentation of very labile peptides in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem 2009, 81(21):8986-8992.
19. Suckau D., Resemann A. T3-sequencing: targeted characterization of the N- and C-termini of undigested proteins by mass spectrometry. Anal Chem 2003, 75(21):5817-5824.
20. Kocher T., Engstrom A., Zubarev R.A. Fragmentation of peptides in MALDI in-source decay mediated by hydrogen radicals. Anal Chem 2005, 77(1):172-177.
21. Calligaris D., Villard C., Terras L., Braguer D., Verdier-Pinard P., Lafitte D. MALDI in-source decay of high mass protein isoforms: application to alpha- and beta-tubulin variants. Anal Chem 2010, 82(14):6176-6184.
22. Carabetta V.J., Li T., Shakya A., Greco T.M., Cristea I.M. Integrating Lys-N proteolysis and N-terminal guanidination for improved fragmentation and relative quantification of singly-charged ions. J Am Soc Mass Spectrom Jun 2010, 21(6):1050-1060.
23. Franck J., Longuespée R., Wisztorski M., Van Remoortere A., Van Zeijl R., Deelder A., et al. MALDI mass spectrometry imaging of proteins exceeding 30,000daltons. Med Sci Monit Sep 2010, 16(9):BR293-BR299.
24. Taban I.M., Altelaar A.F., van der Burgt Y.E., McDonnell L.A., Heeren R.M., Fuchser J., et al. Imaging of peptides in the rat brain using MALDI-FTICR mass spectrometry. J Am Soc Mass Spectrom 2007, 18(1):145-151.
25. Lagarrigue M., Becker M., Lavigne R., Deininger S.O., Walch A., Aubry F., et al. Revisiting rat spermatogenesis with MALDI imaging at 20-microm resolution. Mol Cell Proteomics 2011, 10(3). [M110 005991].
26. Katsetos C.D., Del Valle L., Geddes J.F., Assimakopoulou M., Legido A., Boyd J.C., et al. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas. Arch Pathol Lab Med 2001, 125(5):613-624.
27. Katsetos C.D., Del Valle L., Geddes J.F., Aldape K., Boyd J.C., Legido A., et al. Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status. J Neuropathol Exp Neurol 2002, 61(4):307-320.
28. Katsetos C.D., Draberova E., Smejkalova B., Reddy G., Bertrand L., de Chadarevian J.P., et al. Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells. Neurochem Res 2007, 32(8):1387-1398.